Factors Influencing the Distribution of Metastases and Survival in Extensive Disease Small Cell Lung Cancer

References

• Matthews MJ. Problems in morphology and behavior of bronchopulmonary malignant diseases. In: Israel L, Chahinian AP, eds. Lung cancer: natural history, prognosis, and therapy. New York: Academic Press, 1976: 23–62.
   Google Scholar
• Ihde DC, Hansen HH. Staging procedures and prognostic factors in small cell carcinoma of the lung. In: Greco FS, Oldman RK, Bunn PA, eds. Small cell lung cancer. New York: Grune&Stratton, 1981: 261–83.
   Google Scholar
• Abrams J, Doyle YA, Aisner J. Staging, prognostic features, and special considerations in small cell lung cancer. Semin Oncol 1988; 15: 261–77.
   Google Scholar
• Ihde DC. Staging evaluation and prognostic factors in small cell lung cancer. In: Aisner J, ed. Lung cancer. New York: Churchill Livingstone, 1985: 241–68.
   Google Scholar
• Crane JM, Nelson MJ, Ihde DC, et al. A comparison of computed tomography and radionuclide scanning for detec-tion of brain metastases in small cell lung cancer. J Clin Oncol 1984; 2: 1017–24.
   PubMed Web of Science ®Google Scholar
• Giannone L, Johnson DH, Hande KR, Greco FA. Favorable prognosis of brain metastases in small cell lung cancer. Ann Intern Med 1987; 106: 386–9.
   PubMedGoogle Scholar
• Van Hazel G, Scott M, Eagan RT. The effect of CNS metastases on the survival of patients with small cell cancer of the lung. Cancer 1983; 51: 933–7.
   Google Scholar
• Maurer LH, Pajak TJ. Prognostic factors in small cell car-cinoma of the lung. A cancer and leukemia group B study. Cancer Treat Rep 1981; 65: 767–74.
   PubMed Web of Science ®Google Scholar
• Dearing M, Steinberg S, Phelps R, et al. Outcome of patients with small cell lung cancer: effect of changes in staging procedures and imaging technology on prognostic factors over 14 years. J Clin Oncol 1990; 8: 1042–9.
   PubMedGoogle Scholar
• Livingstone RB, McCraken JD, Trauth CJ, Chen T. Isolated pleural effusion in small cell lung carcinoma: favorable prog-nosis. Chest 1982; 81: 208–11.
   PubMedGoogle Scholar
• Mirvis SE, Whitley NO, Aisner J, Moody M, Whitacre M, Whitley JE. Abdominal CT in the staging of small cell carcinoma of the lung: incidence of metastases and effect of prognosis. AJR 1987; 148: 845–7.
   PubMedGoogle Scholar
• Sagman U, Feld R, Evans WK, et al. The prognostic signifi-cance of pretreatment serum lactate dehydrogenase in patients with small cell lung cancer. J Clin Oncol 1991; 9: 954–61.
   PubMed Web of Science ®Google Scholar
• Kristjansen PE, Osterlind K, Hansen M. Detection of bone marrow relapse in patients with small cell carcinoma of the lung. Cancer 1986; 58: 2538–41.
   Google Scholar
• Livingston RB, Trauth CJ, Greenstreet RL. Small cell car-cinoma: clinical manifestations and behavior with treatment. In: Greco FA, Oldham RK, Bunn PA, eds. Small cell lung cancer. Orlando: Grune&Stratton, 1981: 285–300.
   Google Scholar
• Albain KS, Crowley JJ, LeBlanc M, Livingstone RB. Deter-minants of improved outcome in small cell lung cancer. An analysis of the 2 580 patients Southwest Oncology Group Data. J Clin Oncol 1990; 8: 1563–74.
   PubMed Web of Science ®Google Scholar
• Rawson NSB, Peto J. An overview of prognostic factors in small cell lung cancer. A report from the subcommittee for the management of lung cancer of the United Kingdom Coordinating Committee in Cancer Research. Br J Cancer 1990; 61: 597–604.
   Google Scholar
• Spiegelman D, Maurer LH, Ware JH, et al. Prognostic factors in small cell carcinoma of the lung. An analysis of 1 521 patients. J Clin Oncol 1989; 7: 344–54.
   PubMedGoogle Scholar
• Sagman U, Maki E, Evans WK, et al. Small cell carcinoma of the lung. Derivation of a prognostic staging system. J Clin Oncol 1991; 9: 1639–49.
   PubMedGoogle Scholar
• Lenhard RE, Woo AB, Abeloff MD. Predictive value of regression rates following chemotherapy of small cell car-cinoma of the lung. Cancer Res 1983; 43: 3013–7.
   Google Scholar
• Cohen MH, Makuch RW, Johnson-Early A, et al. Labora-tory parameters as an alternative to performance status in prognostic stratification. Of patients with small cell lung cancer. Cancer Treat Rep 1981; 65: 187–95.
   Google Scholar
• Cerny T, Blair V, Anderson H, Bramwell V, Thatcher N. Pretreatment prognostic factors and scoring system in 407 small cell lung cancer patients. Int J Cancer 1987; 39: 146–9.
   Google Scholar
• Siu LL, Shephard FA, Murray N, Feld R, Pater J, Zee B. Influence of age in the treatment of limited stage small cell lung cancer. J Clin Oncol 1996; 14: 821–8.
   PubMed Web of Science ®Google Scholar
• Wolf M, Holle R, Hans K, Drings P, Havemann K. Analysis of prognostic factors of 766 patients with small cell lung cancer: the role of sex as a predictor of survival. Br J Cancer 1991; 63: 986–92.
   Google Scholar
• Johnson BE, Steinberg SM, Phelps R, Edison M, Veach SR, Ihde DC. Female patients with small cell lung cancer live longer than male patients. Am J Med 1988; 85: 194–6.
   PubMed Web of Science ®Google Scholar
• Osterlind K, Hansen HH, Hansen M, Dombernowsky P, Andersen PK. Long-term disease-free survival in small cell carcinoma of the lung. A study of clinical determination. J Clin Oncol 1986; 4: 1307–13.
   Google Scholar
• Souhami RL, Bradbury I, Geddes DM, Spiro SG, Harper PG, Tobias JS. Prognostic significance of laboratory parame-ters researched at diagnosis in small cell cancer of the lung. Cancer Res 1985; 45: 2878–82.
   PubMedGoogle Scholar
• Ihde DC, Makuch RW, Carney DN, et al. Prognostic impli-cations of stage of disease and site of metastases in patients with small cell carcinoma of the lung treated with intensive combination chemotherapy. Am Rev Respir Dis 1981; 123: 500–7.
   PubMed Web of Science ®Google Scholar